RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 121 filers reported holding RA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $989,000 | -3.3% | 20,601 | -5.5% | 0.01% | +25.0% |
| Q4 2019 | $1,023,000 | +96.7% | 21,793 | -0.8% | 0.00% | +100.0% |
| Q3 2019 | $520,000 | -13.2% | 21,975 | +10.4% | 0.00% | 0.0% |
| Q2 2019 | $599,000 | +122.7% | 19,911 | +66.0% | 0.00% | +100.0% |
| Q1 2019 | $269,000 | +55.5% | 11,992 | +26.1% | 0.00% | 0.0% |
| Q4 2018 | $173,000 | 0.0% | 9,511 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $173,000 | +84.0% | 9,584 | +1.8% | 0.00% | – |
| Q2 2018 | $94,000 | +70.9% | 9,410 | -8.9% | 0.00% | – |
| Q1 2018 | $55,000 | -17.9% | 10,332 | +30.5% | 0.00% | – |
| Q4 2017 | $67,000 | -41.7% | 7,919 | +0.5% | 0.00% | – |
| Q3 2017 | $115,000 | -16.1% | 7,881 | +8.1% | 0.00% | – |
| Q2 2017 | $137,000 | +34.3% | 7,292 | +51.5% | 0.00% | – |
| Q1 2017 | $102,000 | – | 4,814 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |